Opin vísindi

Fletta eftir höfundi "Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium"

Fletta eftir höfundi "Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium"

Röðun: Raða: Niðurstöður:

  • Icon
    Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2 
    AOCS Group; CZECANCA Consortium; The Consortium of Investigators of Modifiers of BRCA1/2; Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium; HEBON Investigators; GEMO Study Collaborators (2023-06)
    Background: The distribution of ovarian tumour characteristics differs between germline BRCA1 and BRCA2 pathogenic variant carriers and non-carriers. In this study, we assessed the utility of ovarian tumour characteristics as predictors of BRCA1 and ...